HuGE Literature Finder
Records
1
-
1
Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients. Molecular and clinical oncology 2014 Sep 2 (5): 714-718. Yashima Hideaki, Shimizu Kimihiro, Araki Takuya, Aomori Tohru, Ohtaki Yoichi, Nagashima Toshiteru, Enokida Yasuaki, Atsumi Jun, Nakamura Tomonori, Takeyoshi Izumi, Yamamoto Koujir |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: